Privia Health Group, Inc. (PRVA)

Privia Health Group, Inc. has experienced positive stock momentum, rising by 10.41% over the last month and 47.92% over the past year. On May 20, 2024, PRVA reached an all-time low of $15.92. For the second quarter of 2025, Privia Health reported revenue that exceeded expectations but EPS lagged behind estimates; revenue for the last quarter amounted to $521.15 million, surpassing the estimated $467.04 million, but the reported EPS of $0.02 was a significant miss compared to the estimated $0.05. The company lifted its revenue guidance for the full year 2025 to $1.9 billion at the midpoint. In September 2025, Privia Health announced its acquisition of the ACO business from Evolent Health for up to $113 million. Analyst ratings for PRVA generally lean positive, with an average rating of 'Moderate Buy' and a consensus price target of $28.91.

Information regarding specific demand seasonality for Privia Health Group, Inc.'s products and services was not explicitly detailed. The company's revenue model is largely based on partnership agreements, technology licensing, and value-based care contracts, which often involve recurring fees and shared savings rather than direct seasonal product sales. The company's focus on expanding its provider network and attributed lives suggests a more continuous growth strategy rather than one tied to seasonal fluctuations.

Privia Health Group, Inc. is a national physician enablement company that collaborates with medical groups, health systems, and payers to optimize physician practices and enhance patient care. Founded in 2007 and headquartered in Arlington, Virginia, Privia Health operates within the healthcare sector, specifically in the Health Information Services and Practice Management industries. The company offers a technology platform that integrates EHR, practice management tools, and patient engagement solutions. Privia Health also provides value-based care solutions, telehealth and virtual care solutions, and comprehensive practice management services.

Privia Health operates across multiple states in the U.S., serving thousands of providers and millions of patients through over 1,000 practice locations. The company's footprint extends to 15 markets across the U.S., including states such as California, Connecticut, Delaware, Florida, Georgia, Maryland, Montana, North Carolina, Tennessee, Texas, and Virginia.

Privia Health Group, Inc. maintains a generally positive brand reputation, driven by its mission to empower physicians and enhance patient experiences through technology and value-based care. Analysts have a favorable view of the company, with a consensus rating of 'Moderate Buy' and a projected upside potential based on their price targets. The company's consistent growth and profitability, along with its focus on improving care quality and reducing costs through its ACOs, contribute to its positive standing in the healthcare industry. There have been no specific events reported in the past year that have negatively impacted Privia Health Group, Inc.'s brand reputation.

Institutional investors hold a substantial majority of Privia Health Group, Inc. stock, with ownership percentages ranging from 94.48% to 97.06%. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC significantly increased its holdings by 180.4% in the first quarter, bringing its total to 2,633,040 shares. Other institutions that have modified their holdings include Charles Schwab Investment Management Inc., Nuveen LLC, Van Berkom & Associates Inc., and Northern Trust Corp.